Genmab — April 2017
-
-
Citat fra Børsen : Forsøget skal sammenligne Dara i combi med Pom - Dex hos patienter som tidligere har fået anden type behandling. Studiet starter Q 2 -17. Vi er meget tilfredse med at se dette fase III påbegyndt siger JvdW i følge pressemeddellelse fra Genmab og tilføjer at studiet kan betyde en ny tilgang til behandling af denne type patienter. Citat slut.
-
Godmorgen.
-
Er den her fra igår ?Genmab Announces New Phase III Combination Study of Daratumumab in Multiple Myeloma
PDF
Company Announcement
Phase III study of daratumumab in combination with pomalidomide and dexamethasone in relapsed and refractory multiple myeloma
Collaborative study between European Myeloma Network and Janssen
Study expected to start Q2 2017 -
Det er den fra i går.
-
Teknisk analyse af Genmab: https://www.youtube.com/watch?v=djSXVEgs_S0&feature=youtu.be&a
-
Helt frisk video https://www.youtube.com/watch?v=hcbCIWNUQpk
-
Jeg forstår ikke det med gap ned fra 1.405.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind